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Available online 16 August 2011Abstract Naturally-occurring, endogenous electric fields (EFs) have been detected at skin wounds, damaged tissue sites
and vasculature. Applied EFs guide migration of many types of cells, including endothelial cells to migrate directionally.
Homing of endothelial progenitor cells (EPCs) to an injury site is important for repair of vasculature and also for angiogenesis.
However, it has not been reported whether EPCs respond to applied EFs. Aiming to explore the possibility to use electric
stimulation to regulate the progenitor cells and angiogenesis, we tested the effects of direct-current (DC) EFs on EPCs.
We first used immunofluorescence to confirm the expression of endothelial progenitor markers in three lines of EPCs. We
then cultured the progenitor cells in EFs. Using time–lapse video microscopy, we demonstrated that an applied DC EF directs
migration of the EPCs toward the cathode. The progenitor cells also align and elongate in an EF. Inhibition of vascular
endothelial growth factor (VEGF) receptor signaling completely abolished the EF-induced directional migration of the
progenitor cells. We conclude that EFs are an effective signal that guides EPC migration through VEGF receptor signaling in
vitro. Applied EFs may be used to control behaviors of EPCs in tissue engineering, in homing of EPCs to wounds and to an
injury site in the vasculature.
© 2011 Elsevier B.V. All rights reserved.Abbreviations: EPCs, endothelial progenitor cells; DC, direct-
current; EFs, electric fields; VEGF, vascular endothelial growth factor.
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Directional migration of endothelial progenitor cells (EPCs)
is critical in vasculogenesis, angiogenesis, and vasculature
repair. In embryos, EPCs migrate, differentiate, and coa-
lesce into clusters of hemangioblasts to form new blood ves-
sels (vasculogenesis). In adults, EPCs may move to sites of
injury or a site of neovascularization and then differentiate
into mature endothelial cells, thus contributing to re-
39Electrotaxis of endothelial progenitor cellsendothelialization and neo-vascularization (angiogenesis)
(Asahara et al., 1997; Akeson et al., 2000; Iwatsuki et al.,
2005; Shi et al., 1998). Injury to vascular endothelium
leads to the loss of the anti-thrombotic properties of the ves-
sel wall, which could result in thrombosis, intimal hyperpla-
sia and stenosis (Asahara et al., 1997; Zhao et al., 2008).
Minor damage may be repaired by migration and prolifera-
tion of surrounding mature endothelial cells. Larger damage
requires migration and differentiation of EPCs that are
marked in general by CD133+/CD34+/vascular endothelial
growth factor receptor 2+ (VEGFR-2)/VE-cadherin− (Akeson
et al., 2000, 2001, 2010; Yamashita et al., 2000; Hristov
and Weber, 2004, 2008).
Directional migration of EPCs is meditated by varied che-
mokines, extracellular matrix, growth factors and mem-
brane receptors (Hristov and Weber, 2004, 2008). Vascular
endothelial growth factor (VEGF) is the most importantFigure 1 Expression of progenitor markers. The three cell lines M
markers for endothelial progenitor cells: CD133 (green), VEGFR2 (re
nucleus. Scale bars=10 μm.growth factor in angiogenesis, controlling and increasing
blood vessel formation (Yamashita et al., 2000; Yancopoulos
et al., 2000).
Endogenous electric fields (EFs) occur naturally at
wounds and around vasculature, which may be an important
signal in guiding cell migration (McCaig et al., 2005; Zhao et
al., 2006; Nuccitelli, 2003; Barker et al., 1982). Applied EFs
induced important pre-angiogenic responses in mature endo-
thelial cells in culture. Human umbilical vein endothelial
cells, bovine aortic endothelia cells, human dermal micro-
vascular endothelial cells respond to applied EFs by direc-
tional migration, elongation and alignment (Li and Kolega,
2002; Bai et al., 2004; Zhao et al., 2004).
Importantly, electrical stimulation has been demonstrat-
ed as an effective approach to induce angiogenesis in ische-
mia and wound healing (Zhao et al., 2004; Patterson and
Runge, 1999; Kanno et al., 1999; Linderman et al., 2000;FLM-4 (A), AEL-deltaR1/Runx1 (B), and AEL-deltaR1 (C) express
d), and von Willebrand Factor (green). Blue is DAPI staining for
Figure 2 Electric field-directed migration of MFLM-4 cells. A DC EF directs EPCs (MFLM-4) to migrate to the cathode. Reversing the
polarity of the EF reversed the cell migration direction. (A) Time lapse photographs of cell migration in an EF for 6 h. Arrows show
direction of the cells migrated. Outlines (A′) of the labeled cells from 3 to 6 h highlight cell migration. Cells are traced starting
from 3 h for clarity. (B) Composite graphs of cell trajectories without an EF. The trajectories of the cells are arranged with the start-
ing position of each cell placed at the origin. Cells migrated without preferred direction. (C) Application of an EF induced directional
cell migration to the cathode on the right. (D) Reversing the EF reversed the directional cell migration to the new cathode on the left.
Values of mean directedness±SEM are shown. (E) Voltage dependence of the directional cell migration. All data were calculated from
three independent experiments. **: Pb0.01 compared with no EF. Scale bars=50 μm.
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41Electrotaxis of endothelial progenitor cellsSheikh et al., 2005; Kloth, 2005; Nagasaka et al., 2006).
Electrical stimulation significantly enhances angiogenesis in
ischemic and non-ischemic rat limbs, possibly mediated by
VEGF and hepatocyte growth factor (HGF) expressed in mus-
cle cells (Kanno et al., 1999; Sheikh et al., 2005; Nagasaka et
al., 2006; Hang et al., 1995). Small EFs directly stimulate
VEGF production by endothelial cells and direct reorienta-
tion, elongation and migration of endothelial cells in cul-
ture, through phosphatidylinositol 3-kinase (PI3K)-protein
kinase B (PKB or Akt), Rho-ROCK signaling pathways (Bai et
al., 2004; Zhao et al., 2004).
It has not been reported whether behaviors of EPCs can
be regulated by applied EFs. To be able to manipulate cellu-
lar behaviors of EPCs, and to direct EPCs to sites where an-
giogenesis is required, may have significant clinical
implication in tissue engineering, and in controlling angio-
genesis and many angiogenesis-related diseases. Directed
migration of endothelial cells in an EF appears to be cell-
type and origin specific. The endothelial cells from human
microvasculature (HMEC-1 cells) or cultured bovine aorta
migrated toward the cathode, whilst the endothelial cells
derived from human umbilical vein migrated toward the
anode (Li and Kolega, 2002; Bai et al., 2004). It is therefore
necessary to determine the responses of EPCs. We report
here that DC EFs are a very powerful signal to direct migra-
tion, orientation, and elongation of three different types of
EPCs. The EF-guided cell migration appears to be mediated
by VEGF receptors.-10
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Expression of the progenitor markers on the three
cell lines
We used the MFLM-4, AEL-deltaR1 and AEL-deltaR1/Runx1-
cells, because they are relatively well studied murine endo-
thelial progenitor cells. Using those cells offer a basis to do
further in vitro and in vivo genetic studies with mouse
models. Progenitor cell marker CD133, and endothelial
cell markers VEGFR-2 and von Willebrand Factor (vWF)
were used to confirm the endothelial progenitor cell nature.
These combined proteins are the markers used to identify
EPCs. We confirmed that the three cell lines (MFLM-4, AEL-
deltaR1 and AEL-deltaR1/Runx1) are all positive with specif-
ic stem cell marker-CD133 and endothelial cell markers-vWF
and VEGFR-2 (Fig. 1).0
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Figure 3 MFLM-4 cell response in small physiological EFs.
(A) Trajectory speed (Tt/T) and voltage dependence of dis-
placement speed (Td/T) and displacement speed along the
X axis (Dx/T). (B) Voltage dependence of orientation index.
(C) Long/short axis ratio in different EFs. All data were calculat-
ed from three independent experiments. *: Pb0.05; **: Pb0.01
compared with no EF.Directed migration of the progenitor cells by EFs
MFLM-4 cells migrated toward the cathode in EFs of 150–
400 mV/mm (Fig. 2; Supplementary video 1). Significant di-
rectional migration occurred at a field strength of
150 mV/mm with migration directedness of 0.24±0.07
(n=101; Pb0.01 compared with that of no EF control:
−0.01±0.06, n=141, Fig. 2E). When the EF polarity was re-
versed, cells rapidly changed direction to move toward
the new cathode (Figs. 2C, D). This reversal of the migration
direction can be observed ~15 min after reversing the polarity
of the applied EF. The cell directedness was voltage-dependent (Pb0.05; Fig. 2E). Cell migration speed along the
X axis (Dx/T) significantly increased when exposed to EFs of
150–400 mV/mm. Straight-line migration speed (Td/T) also
significantly increased in EFs of 200–400 mV/mm (Pb0.05
compared with no EF control; Fig. 3A).
MFLM-4 cells cultured without an EF had flat spindle-
shaped morphology, with the long axis of the cell body ori-
ented randomly (e.g. 0 h in Figs. 2A; 3B). In contrast, cells
cultured in DC EFs were re-orientated with their long axes
aligning perpendicular to the vector of the applied EF (e.g.
4 h in Figs. 2A; 3B). The orientation index increased gradual-
ly when the strength of the applied EFs increased from 150
to 400 mV/mm (Pb0.05 compared with no EF control;
Fig. 3B). EF had no effect on MFLM-4 cell shape, as assessed
by long/short axis ratio (Fig. 3C).
Next, AEL-deltaR1 and AEL-deltaR1/Runx1cells were test-
ed. In the absence of an applied EF, AEL-deltaR1 cells migrat-
ed randomly, with an average net directedness of 0.04±0.07
42 Z. Zhao et al.and displacement speed along the X axis of 0.23±0.75 μm/h.
At an EF of 300 mV/mm, cells had clear response toward the
cathode, with an average net directedness of 0.66±0.05 and
displacement speed along the X axis of 7.35±0.72 μm/h
(Pb0.001 compared with no EF control; Figs. 4A–C; 5A; Sup-
plementary video 2). Cells extended cathode-directed lamel-
lipodia and began directed migration toward the cathode
within 5 min of switching the EF on (Fig. 4A). The cells re-
oriented to align perpendicular to the EF vector (Fig. 5B). Mi-
grating cells extended membrane protrusions preferentially
toward the cathode, either from the leading edge, or at both
ends of the long axis (Fig. 4A; Supplementary video 2). EF ex-
posure significantly induced cell elongation (Pb0.001 com-
pared with no EF control; 3 h in Figs. 4A; 5C; Supplementary
video 2).
AEL-deltaR1/Runx1 cells also migrated toward the cathode
at an EF of 300 mV/mm, with an average net directedness-100
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Figure 4 An applied EF directs migration of two other EPC cell l
(300 mV/mm). (D–F) AEL-deltaR1/Runx1 cell response in small phys
gration in an EF. (B, E) Composite graphs of migration trajectories
right in an EF. (C, F) Directedness of cell migration. All data were ca
pare with no EF. Scale bar=50 μm.of 0.47±0.05 and displacement speed along the X axis of
10.60±1.20 μm/h (Pb0.001 compared with no EF control di-
rectedness of 0.01±0.06 and displacement speed along the X
axis of 0.13±1.49 μm/h; Figs. 4D–F; 5D; Supplementary
video 3). Cells reoriented to align perpendicular to the EF vec-
tor like AEL-deltaR1 (Figs. 4D; 5E; Supplementary video 3) but
EF exposure did not induce AEL-deltaR1/Runx1 cell elongation
(P>0.05 compared with no EF control; Figs. 4D; 5F; Supple-
mentary video 3).MFLM-4 cell electrotactic migration requires
VEGFR-2 activation
VEGF receptor signaling is critical in the control of many en-
dothelial cell behaviors and angiogenesis. Our previous
work has shown that electric field-directed human umbilical-100
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Figure 5 AEL-deltaR1 and AEL-deltaR1/Runx1 cell response in an EF (300 mV/mm). (A–C) AEL-deltaR1 cells. (D–F) AEL-deltaR1/
Runx1 cells. (A, D) Trajectory speed (Tt/T), displacement speed (Td/T), and displacement speed along the X axis (Dx/T). (B, E) Ori-
entation index. (C, F) Long/short axis ratio. All data were calculated from three independent experiments. **: Pb0.01 compared with
no EF.
43Electrotaxis of endothelial progenitor cellsvein endothelial cell migration is mediated through
VEGFR signaling (Zhao et al., 2004). In the present study,
the activity of VEGFR-2 was investigated. Addition of
VEGF (100 ng/ml) significantly enhanced directional MFLM-
4 cell migration toward the cathode. Both the direc-
tedness (113%; Pb0.05) and displacement speed along
the X axis (124%; Pb0.05) were significantly increased
in culture medium containing VEGF (100 ng/ml) (Fig. 6;
Supplementary video 4). Cell orientation and elongation
were not influenced by VEGF (Figs. 7A, B; Supplementary
video 4).
Inhibition of VEGFR-2 with a specific VEGFR-2 Kinase In-
hibitor II (VEGFR-2I) at 50 μM completely abolished the di-
rectness (4%; Pb0.001) and decreased migration speed (Tt/
T 53%; Pb0.001; Td/T 41%; Pb0.001; Dx/T 1%; Pb0.001) of
MFLM-4 cells in an EF (Fig. 6). The inhibition of the direct-
ness and migration speed was dose-dependent (Fig. 6; Sup-
plementary video 5 and 6).
The VEGFR-2 kinase inhibitor (50 μM) completely abol-
ished the MFLM-4 cell orientation response (Fig. 7A; Supple-
mentary video 6). The Oi (orientation index) values of the
cells treated with VEGFR-2 inhibitor were 0.12±0.07 and
−0.08±0.07 in EF for 1 μM and 50 μM, respectively. Thelatter is significantly different from the non-inhibitor-
treated values of 0.18±0.07 (Pb0.01; Fig. 7A).Discussion
DC EFs are present naturally at wounds and are a powerful
cue that directs polarization and migration of epithelial
cells, fibroblast cells, and vascular endothelial cells (McCaig
et al., 2005; Bai et al., 2004; Zhao et al., 2004; Pu and Zhao,
2005). Electrical stimulation induces pre-angiogenic re-
sponses in endothelial cells and therefore may contribute
to the regulation of angiogenesis (Patterson and Runge,
1999; Kanno et al., 1999; Linderman et al., 2000; Sheikh et
al., 2005; Kloth, 2005; Nagasaka et al., 2006). EPCs are a
key player in vascular repair and angiogenesis (Akeson et
al., 2000, 2001, 2010; Yamashita et al., 2000; Hristov and
Weber, 2004, 2008; Hristov et al., 2007). We report the
novel effects of applied EFs on three independent endotheli-
al progenitor cell lines. We confirmed the progenitor nature
of the cells. All three EPCs respond to an applied EF by direc-
tional migration toward the cathode. Such responses
depended on VEGF receptor signaling.
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Figure 6 Activation of VEGFR-2 is required for electrotactic
response of EPCs. (A) Directedness of cell migration was abol-
ished when VEGFR-2 was inhibited with VEGFR2I. (B) Trajectory
speed, displacement speed, and displacement speed along the X
axis of cell migration were also affected with VEGFR2I. VEG-
FR2I=VEGF receptor 2 inhibitor. All data were calculated from
three independent experiments. *: Pb0.05; **: Pb0.01 com-
pared with control (no EF).
0
2
4
6
-0.2
0
0.2
0.4
O
rie
nt
at
io
n 
in
de
x
A
Lo
ng
/s
ho
rt 
ax
is
 ra
tio
B
Control VEGFR2I
1μM 50μM 
VEGFR2I VEGF 
100 ng/ml
300 mV/mm
Control VEGFR2I
1μM 50μM 
VEGFR2I VEGF 
100 ng/ml
300 mV/mm
∗∗
∗
∗
∗
Figure 7 Activation of VEGFR-2 is required for response of
EPCs to an applied EF. (A) Orientation index. (B) Long/short
axis ratio. VEGFR2I=VEGF receptor 2 inhibitor. All data were
calculated from three independent experiments. *: Pb0.05: **:
Pb0.01 compared with control (no EF).
44 Z. Zhao et al.Migration of EPCs and the possible role of focal EFs
EPCs circulate in the blood stream and contribute to re-
endothelialization of injured vessels as well as neovascular-
ization of ischemic lesions. A decrease in the number of
EPCs is an independent predictor of morbidity and mortality
of cardiovascular diseases. It is therefore suggested that
EPCs play a major role in the pathogenesis of atherosclerosis
and cardiovascular diseases (Asahara et al., 1997; Hristov et
al., 2007). EPCs may come from the stem cell pool in the cir-
culating blood and migrate or be recruited to the wound site
(Shi et al., 1998; Hristov and Weber, 2004, 2008; Hristov et
al., 2007; Takahashi et al., 1999).
Many factors may control homing of EPCs to damaged or
angiogenesis sites. The specific mechanisms are not clear.
Chemokines and cytokines, such as VEGF and many others,
affect the migration and population of EPCs (Hristov and
Weber, 2004, 2008; Takahashi et al., 1999; Gurtner and
Chang, 2008; Peichev et al., 2000; Zemani et al., 2008). Un-
derstanding the controlling mechanisms of EPC homing to
damaged or angiogenesis sites and developing effective ap-
proaches to facilitate EPC migration will be of great clinical
significance.
Vasculature is associated with many electric activities. In
many cases, angiogenesis occurs in the presence of endoge-
nous EFs, which are generated by active ion transport acrosspolarized epithelia and endothelia (McCaig et al., 2005;
Zhao et al., 2006; Barker et al., 1982; Nuccitelli, 1992;
Hotary and Robinson, 1992; McCaig and Zhao, 1997). There
are several types of electric potential differences around
the endothelium of blood vessels that might be involved in
regulating the development of thromboses (Sawyer and
Pate, 1953). The ζ (streaming) potentials, for example, are
created at the endothelial cell wall by blood flow in both
the aorta and vena cava, and they range from 100 to
400 mV (Sawyer et al., 1966). Injured and ischemic tissue
also becomes electrically polarized relative to surrounding
normal tissue because cells become depolarized and extra-
cellular K+ ions build up in the damaged areas. In the
heart, this leads to a flow of injury current intracellularly
through junctionally-coupled cells, with an extracellular re-
turn loop, and is thought to be involved in arrhythmogenesis
(Coronel et al., 1991). Extracellular injury currents, which
create directly measured DC EFs of 58 mV/cm, extend over
about 8 mm at the boundary between ischemic and normal
tissue (Coronel et al., 1991). Electrical stimulation signifi-
cantly enhances angiogenesis in ischemic and non-ischemic
rat limbs (Kanno et al., 1999; Sheikh et al., 2005; Nagasaka
et al., 2006; Hang et al., 1995).
Directed migration of cells in an EF appears to be cell-
type specific, since some cells types migrate cathodally
and others anodally (McCaig et al., 2005; Zhao et al.,
2006). Mature vascular endothelial cells have been reported
to respond differently. The endothelial cells from human mi-
crovasculature (HMEC-1 cells) or cultured bovine aortic mi-
grated toward the cathode, whilst the endothelial cells
derived from human umbilical vein migrated toward the
anode (Li and Kolega, 2002; Bai et al., 2004). Mouse
45Electrotaxis of endothelial progenitor cellsadipose-derived stromal cells (mASC) migrated toward the
cathode in response to EFs (Hammerick et al., 2010). Howev-
er, human induced pluripotent stem cells (hiPS) show anode
directed migration (Zhang et al., in press). It is therefore nec-
essary to determine the responses of EPCs. We demonstrate
here that three independent lines of EPCs (MFLM-4, AEL-
deltaR1 and AEL-deltaR1/Runx1) respond to applied EFs by di-
rectional cell migration toward the cathode (Figs. 2–5). Our
data therefore confirm the DC EF as a novel, extracellular, per-
haps physiological cue for directing the migration of EPCs.
These results suggest that application of an EF may be a good
candidate to locally modulate recruitment of EPCs.Activity of VEGFR2 in EPC electrotaxis
VEGFR-2 mediates the major actions of VEGF (Yamashita et
al., 2000; Yancopoulos et al., 2000). A selective and potent
VEGFR-2 inhibitor for receptor-2 tyrosine kinase (50% inhibi-
tory concentrations of 70 nM for VEGFR-2) abolished the EF-
directed migration of EPCs (Sun et al., 2000). Inhibition of
VEGFR-2 abolished the directional migration of progenitor
cell MFLM-4 (Fig. 7). PI3Kγ mediates the chemokine-
induced migration of human EPCs. PI3Kγ is involved in the
in vivo homing of progenitor cells to ischemic sites in the
mouse model of hindlimb ischemia. PI3Kγ is also essential
for the in vivo neovascularization-promoting capacity of pro-
genitor cells in ischemic sites (Chavakis et al., 2008). Kawa-
saki and colleagues found that Ras signaling downstream of
VEGFR-2 is involved in specifying endothelial differentiation
of VEGFR-2 positive vascular progenitor cells (Kawasaki et
al., 2008). Electrotaxis of endothelial progenitor cells is like-
ly to share the same signaling pathway of chemotaxis.Physiological relevance of EFs to endothelial repair
and angiogenesis
DC EFs exist in vivo and have profound influences on cell mi-
gration, orientation, and proliferation (McCaig et al., 2005;
Zhao et al., 2006; Nuccitelli, 2003). Disrupting the EFs impairs
development and wound healing (McCaig et al., 2005; Hotary
and Robinson, 1992). Angiogenesis plays a major role in devel-
opment, wound healing and tumor growth, and EPCs are
expected to experience endogenous EFs. These include: ζ
(streaming) potentials created by blood flow, extracellular in-
jury currents produced at the boundary between ischemic and
normal tissue, and altered surface charges that are a hallmark
of the rapid, accelerated proliferation of tumor cells. The
close association of angiogenesis with EFs in vivo and the ef-
fect of EFs on pre-angiogenic responses of EPCs through one
of the most important VEGFR-2 signaling pathways suggest
that EFs might play an important role in angiogenesis in vivo.
The threshold of applied DC EFs to induce these cellular be-
haviors in MFLM-4 is 150 mV/mm. The experimentally mea-
sured EFs near the cuts are 40 mV/mm and 100–200 mV/mm
in bovine cornea and guinea-pig skin, respectively (Barker et
al., 1982; Chiang et al., 1992). The field strength decreases
exponentially within the extracellular distance away from
the wound. Further studies of proliferation and differentiation
with EPCs will determine the EF threshold needed to induce
the responses of the EPCs that are mainly involved inangiogenesis and provide further evaluation of possible roles
physiological EFs might have in vivo.
In conclusion, small DC EFs induce angiogenic responses in
EPCs, causing significant directional migration and orienta-
tion. This is a primary response of the EPCs and does not re-
quire any other cell type. These responses are mediated by
VEGFR-2 activation.
Materials and methods
Chemicals, reagents and solutions
Dulbecco's modified Eagle's medium (DMEM) and CO2 inde-
pendent cell culture medium were obtained from Invitrogen.
VEGF, fetal bovine serum (FBS), poly-L-lysine and gelatin
were purchased from Sigma-Aldrich. Dishes coated with col-
lagen I and fibronectin were from BD BioCoat. VEGF receptor
2 inhibitor was from Calbiochem.
Cell lines and cell culture
MFLM-4 cells (kindly provided by Dr Ann L. Akeson, The Chil-
dren's Hospital Medical Center, Ohio, USA), were maintained
in DMEM (supplemented with 10% FBS, 100 U/ml penicillin,
100 μg/ml streptomycin, 0.25 μg/ml amphotericin B and 1%
L-glutamine) at 37 °C in 5% CO2. This cell line was isolated
and cloned from murine E14.5 lung mesenchyme as described
(Akeson et al., 2000, 2001). AEL-deltaR1 and AEL-deltaR1/
Runx1 cells (kindly supplied by Dr Takahiko Hara, The Tokyo
Metropolitan Institute of Medical Science, Japan) were main-
tained in DMEM (with the same supplemented chemicals as
for MFLM-4, except without amphotericin B) at 32.5 °C in 5%
CO2. AEL-deltaR1 cell line was established from the aorta-
gonad-mesonephros region of Runx1-null mouse embryos
(Iwatsuki et al., 2005). AEL-deltaR1 cell line transfected with
Runx1 cDNA were named AEL-deltaR1/Runx1; Runx1 is associ-
ated with endothelial cell differentiation (Iwatsuki et al.,
2005). In our pre-experimental observations, these three pro-
genitor cell lines migrated faster on collagen I than on tissue
culture plastic dishes or dishes coated with fibronectin, poly-
L-lysine, or gelatin (data not shown). All the results presented
are from cells cultured on collagen I.Immunofluorescence microscopy
For immunofluorescence staining, cells were fixed in 4% para-
formaldehyde (15 min), permeabilized (5 min in 0.2% Triton X-
100), and blocked for 30 min with blocking solution (10% goat
serum, 1% BSA and 0.02% NaN3 in PBS). A polyclonal antibody
against CD133 (1:200, Abcam) was used to label CD133 (stem
cell marker) for 1 h at room temperature. Antibodies against
von Willebrand Factor (vWF, or Factor VIII-related antigen)
(1:200, Sigma) and monoclonal antibodies against VEGF
receptor-2 (KDR) (1:500, Sigma) were used to confirm the
cell endothelial nature. Cells were incubated for 1 h in solu-
tion with the primary antibodies at room temperature. After
washing, the cells were incubated with phalloidin-FITC
(1:100 Sigma) and Texas Red-conjugated secondary antibodies
(1:200 Jackson Immuno Research Laboratories) for 1 h at room
temperature. Nuclei were stained with DAPI. Images were
46 Z. Zhao et al.obtained with a Zeiss inverted fluorescence microscope (Axio-
vert 100) controlled with MetaMorph software. A 40x Fluor oil-
immersion lens was used.Electrotaxis assay
Cell motility was assayed using an electrotaxis apparatus as pre-
viously detailed (Zhao et al., 2006). Briefly, a DC EF was applied
through agar-salt bridges connecting silver/silver chloride elec-
trodes in beakers of Steinberg's solution to pools of culture me-
dium on either side of the chamber. A roof of No. 1 coverglass
was applied and sealed with silicone grease (Corning DC4).
The final dimensions of the chamber, through which current
was passed, were 40 mm×10 mm×0.2 mm. Immediately before
EF application, CO2-independent medium (including 10% FBS,
100 U/ml penicillin, and 100 μg/ml streptomycin) was trans-
ferred into the culture chambers. Cells were exposed to an EF
for 2–6 h at 37 °C in a temperature-controlled chamber on an
inverted microscope stage. Serial time-lapse images were
recorded using MetaMorph.
Quantitative analysis of cell behavior
We analyzed and quantified the directional cell migration
(directedness) and migration rates by tracing the positions
of cell nuclei at a frame interval of 5 min using MetaMorph
software (Zhao et al., 2006). The directedness of migration
was defined as cosine θ (Zhao et al., 2006), where θ is the
angle between the EF vector and a straight line connecting
the start and end position of a cell. A cell moving directly
along the field lines toward the cathode would have a direct-
edness of 1; a cell moving directly toward the anode would
have a directedness of −1. The cosine θ will provide a num-
ber between −1 and +1 and the average of all of the sepa-
rate cell events yields an average directedness index. The
average directedness of a population of cells gives an objec-
tive quantification of how directional cells have moved in re-
lation to the EF vector. A mean value close to 0 for a
population of cells represents random cell movement.
The trajectory speed (Tt/T) is the total length of the tra-
jectory (Tt) a cell migrated divided by the time (T). The
displacement speed (Td/T) is the straight-line distance be-
tween the start and end positions of a cell (Td) divided by
time (T). Displacement along the X axis (Dx/T) is the projec-
tion of the cell trajectory on the X axis (Dx) divided by the
time (T), which represents the ability of cells to migrate
along the EF vector.
Cell orientation was quantified as an orientation index
(Oi=cos2(α)) (Zhao et al., 2006; Erickson and Nuccitelli,
1984), where α is the angle formed by the long axis of a cell
with a line drawn perpendicular to the field lines. A cell with
its long axis parallel to the vector of the EF will have an Oi of
−1, and a cell with its long axis exactly perpendicular to the
EF vector will have an Oi of +1. A randomly oriented population
of cells will have an average Oi (defined as [∑ncos2(α)]÷n) of 0.
Statistical analysis
Results are presented as mean±standard error of the mean
(SEM). Differences between mean values were comparedusing a two-sample Student's t test, performed with
equal or unequal variance according to an f test. In graphs,
asterisks indicate significant difference (P value in figure
legend); absence of an asterisk indicates no significant
difference.
Supplementary video 1. A DC EF directs migration of MFLM-
4 cells. Time-lapse video corresponding to Fig. 2A shows that
MFLM-4 cells migrate directionally toward the cathode to the
right. The recording time is 6 h with a frame interval of
10 min. EF=300 mV/mm.
Supplementary video 2. Directional migration of AEL-
deltaR1 cells in a DC EF of 300 mV/mm. Time-lapse video
corresponding to Fig. 4A shows that AEL-deltaR1 cells
migrate directionally toward the cathode to the right. The
recording time is 3 h with a frame interval of 5 min.
Supplementary video 3. Directional migration of AEL-
deltaR1/Runx1 cells in a DC EF of 300 mV/mm. Time-lapse
video corresponding to Fig. 4D shows that AEL-
deltaR1/Runx1 cells migrate directionally toward the
cathode to the right. The recording time is 3 h with a
frame interval of 5 min.
Supplementary video 4. Addition of VEGF (100 ng/ml) in-
creases the directional migration of MFLM-4 cells in a DC EF
of 300 mV/mm. The recording time is 2 h with a frame interval
of 5 min.
Supplementary video 5. Effect of VEGFR2I (1 μM) on migra-
tion of MFLM-4 cells in a DC EF of 300 mV/mm. The recording
time is 2 h with a frame interval of 5 min.
Supplementary video 6. VEGFR2I (50 μM) inhibits migra-
tion of MFLM-4 cells in a DC EF of 300 mV/mm. The recording
time is 2 h with a frame interval of 5 min.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.08.001.Acknowledgments
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